Is Zevra Therapeutics, Inc. (ZVRA) a Buy, Sell, or Hold?
NASDAQ : ZVRA
Zevra Therapeutics, Inc.
$12.6792 USD
-$0.28 (-2.17%)
- Volume
- 612.22K
- Average Volume
- 1.69M
- Market Capitalization
- $749.53M
- P/E Ratio
- 5.82
- Dividend Yield
- 0.00%
- Price Target
- $29.00
- Year High
- $15.04
- Year Low
- $7.16
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.89
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
34
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
26
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$844.46K
ZVRA Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ZVRA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Thompson Rahsaan | officer: Chief Legal & Compliance | 2026-06-21 | M-Exempt | 0 | 2026-06-23 |
| Thompson Rahsaan | officer: Chief Legal & Compliance | 2026-06-22 | S-Sale | 12.6835 | 2026-06-23 |
| Thompson Rahsaan | officer: Chief Legal & Compliance | 2026-06-21 | M-Exempt | 0 | 2026-06-23 |
| FAVORITO TAMARA A | director | 2026-06-04 | A-Award | 11.17 | 2026-06-18 |
| Secor Alicia | director | 2026-06-04 | A-Award | 11.17 | 2026-06-18 |
| Watton Corey Michael | director | 2026-06-04 | A-Award | 11.17 | 2026-06-18 |
| Calder Douglas W | director | 2026-06-04 | A-Award | 11.17 | 2026-06-18 |
| Anderson Thomas | director | 2026-06-04 | A-Award | 11.17 | 2026-06-18 |
| Shih Alvin | director | 2026-06-04 | A-Award | 11.17 | 2026-06-18 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | 2026-05-28 | A-Award | 11.4 | 2026-05-29 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | 2026-05-28 | A-Award | 0 | 2026-05-29 |
| Thompson Rahsaan | officer: Chief Legal & Compliance | 2026-05-11 | S-Sale | 11.3 | 2026-05-13 |
| Bode John B | director | 2026-03-24 | M-Exempt | 4.89 | 2026-03-26 |
| Bode John B | director | 2026-03-24 | M-Exempt | 4.97 | 2026-03-26 |
| Bode John B | director | 2026-03-24 | M-Exempt | 4.97 | 2026-03-26 |
| Bode John B | director | 2026-03-24 | M-Exempt | 4.89 | 2026-03-26 |
| Renz Justin A | officer: CFO | 2026-03-18 | A-Award | 9.55 | 2026-03-19 |
| Renz Justin A | officer | 2026-03-18 | 0 | 2026-03-19 | |
| McFarlane Neil F. | director, officer: President and CEO | 2026-02-07 | M-Exempt | 0 | 2026-02-10 |
| McFarlane Neil F. | director, officer: President and CEO | 2026-02-09 | S-Sale | 8.5597 | 2026-02-10 |
| McFarlane Neil F. | director, officer: President and CEO | 2026-02-07 | M-Exempt | 0 | 2026-02-10 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | 2026-02-03 | S-Sale | 9.1827 | 2026-02-04 |
| Schafer Joshua | officer: CCO | 2026-02-03 | S-Sale | 9.1905 | 2026-02-04 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | 2026-01-30 | M-Exempt | 0 | 2026-02-02 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | 2026-01-30 | S-Sale | 8.824 | 2026-02-02 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | 2026-01-30 | M-Exempt | 0 | 2026-02-02 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | 2026-01-29 | A-Award | 8.86 | 2026-02-02 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | 2026-01-30 | M-Exempt | 0 | 2026-02-02 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | 2026-01-30 | S-Sale | 8.8259 | 2026-02-02 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | 2026-01-29 | A-Award | 0 | 2026-02-02 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | 2026-01-30 | M-Exempt | 0 | 2026-02-02 |
| Quartel Adrian W | officer: Chief Medical Officer | 2026-01-29 | A-Award | 8.86 | 2026-02-02 |
| Quartel Adrian W | officer: Chief Medical Officer | 2026-01-29 | A-Award | 0 | 2026-02-02 |
| Quartel Adrian W | officer: Chief Medical Officer | 2026-01-30 | M-Exempt | 0 | 2026-02-02 |
| Quartel Adrian W | officer: Chief Medical Officer | 2026-01-30 | M-Exempt | 0 | 2026-02-02 |
| Quartel Adrian W | officer: Chief Medical Officer | 2026-01-30 | S-Sale | 8.8321 | 2026-02-02 |
| Schafer Joshua | officer: CCO | 2026-01-29 | A-Award | 8.86 | 2026-02-02 |
| Schafer Joshua | officer: CCO | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Schafer Joshua | officer: CCO | 2026-01-30 | M-Exempt | 0 | 2026-02-02 |
| Schafer Joshua | officer: CCO | 2026-01-29 | A-Award | 0 | 2026-02-02 |
| Schafer Joshua | officer: CCO | 2026-01-30 | S-Sale | 8.8297 | 2026-02-02 |
| Schafer Joshua | officer: CCO | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| Schafer Joshua | officer: CCO | 2026-01-30 | M-Exempt | 0 | 2026-02-02 |
| McFarlane Neil F. | director, officer: President and CEO | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| McFarlane Neil F. | director, officer: President and CEO | 2026-02-02 | S-Sale | 9.3783 | 2026-02-02 |
| McFarlane Neil F. | director, officer: President and CEO | 2026-01-29 | A-Award | 8.86 | 2026-02-02 |
| McFarlane Neil F. | director, officer: President and CEO | 2026-01-31 | M-Exempt | 0 | 2026-02-02 |
| McFarlane Neil F. | director, officer: President and CEO | 2026-01-29 | A-Award | 0 | 2026-02-02 |
| Clifton R. LaDuane | other: Former CFO & Treasurer | 2025-12-31 | M-Exempt | 0 | 2026-01-07 |
| Clifton R. LaDuane | other: Former CFO & Treasurer | 2025-12-31 | F-InKind | 8.96 | 2026-01-07 |
| Clifton R. LaDuane | other: Former CFO & Treasurer | 2025-12-31 | M-Exempt | 0 | 2026-01-07 |
| Clifton R. LaDuane | other: Former CFO & Treasurer | 2025-12-31 | M-Exempt | 0 | 2026-01-07 |
| Secor Alicia | director | 2025-12-02 | A-Award | 8.17 | 2025-12-09 |
| Secor Alicia | director: | 2025-12-02 | 0 | 2025-12-09 | |
| McFarlane Neil F. | director, officer: President and CEO | 2025-10-10 | M-Exempt | 0 | 2025-10-10 |
| McFarlane Neil F. | director, officer: President and CEO | 2025-10-10 | S-Sale | 10.8158 | 2025-10-10 |
| McFarlane Neil F. | director, officer: President and CEO | 2025-10-10 | M-Exempt | 0 | 2025-10-10 |
| FAVORITO TAMARA A | director | 2025-09-12 | P-Purchase | 7.7852 | 2025-09-16 |
| Shih Alvin | director | 2025-09-12 | P-Purchase | 7.89 | 2025-09-15 |
| Bode John B | director | 2025-08-19 | P-Purchase | 9.165 | 2025-08-20 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | 2025-06-26 | S-Sale | 9.2085 | 2025-06-30 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | 2025-06-21 | M-Exempt | 0 | 2025-06-24 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | 2025-06-21 | M-Exempt | 0 | 2025-06-24 |
| Shih Alvin | director | 2025-05-29 | A-Award | 8.62 | 2025-05-30 |
| DIXON WENDY L | director | 2025-05-29 | A-Award | 8.62 | 2025-05-30 |
| Calder Douglas W | director | 2025-05-29 | A-Award | 8.62 | 2025-05-30 |
| FAVORITO TAMARA A | director | 2025-05-29 | A-Award | 8.62 | 2025-05-30 |
| Watton Corey Michael | director | 2025-05-29 | A-Award | 8.62 | 2025-05-30 |
| Bode John B | director | 2025-05-29 | A-Award | 8.62 | 2025-05-30 |
| Anderson Thomas | director | 2025-05-29 | A-Award | 8.62 | 2025-05-30 |
| Watton Corey Michael | director | 2025-03-28 | P-Purchase | 7.8384 | 2025-03-31 |
| Quartel Adrian W | officer: Chief Medical Officer | 2025-01-30 | A-Award | 8.02 | 2025-03-27 |
| Quartel Adrian W | officer: Chief Medical Officer | 2025-01-30 | A-Award | 0 | 2025-03-27 |
| Quartel Adrian W | officer: Chief Medical Officer | 2024-12-06 | 0 | 2025-03-27 | |
| Quartel Adrian W | officer: Chief Medical Officer | 2024-12-06 | 6.42 | 2025-03-27 | |
| Bode John B | director | 2025-03-19 | P-Purchase | 7.9624 | 2025-03-21 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | 2025-02-13 | S-Sale | 7.8626 | 2025-02-14 |
| Schafer Joshua | officer: CCO & EVP, Bus. Development | 2025-02-13 | S-Sale | 7.8597 | 2025-02-14 |
| Clifton R. LaDuane | officer: CFO & Treasurer | 2025-02-13 | S-Sale | 7.861 | 2025-02-14 |
| McFarlane Neil F. | director, officer: President and CEO | 2025-02-13 | S-Sale | 7.8571 | 2025-02-14 |
| McFarlane Neil F. | director, officer: President and CEO | 2025-02-14 | S-Sale | 8.0527 | 2025-02-14 |
| McFarlane Neil F. | director, officer: President and CEO | 2025-02-07 | A-Award | 7.77 | 2025-02-10 |
| McFarlane Neil F. | director, officer: President and CEO | 2025-02-07 | A-Award | 0 | 2025-02-10 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | 2025-01-30 | A-Award | 8.02 | 2025-02-03 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | 2025-01-31 | M-Exempt | 0 | 2025-02-03 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | 2025-01-31 | M-Exempt | 0 | 2025-02-03 |
| Sangiovanni Timothy J. | officer: SVP, Finance & Corp Controller | 2025-01-30 | A-Award | 0 | 2025-02-03 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | 2025-01-30 | A-Award | 8.02 | 2025-02-03 |
| Thompson Rahsaan | officer, other: Chief Legal & Compliance | 2025-01-30 | A-Award | 0 | 2025-02-03 |
| Schafer Joshua | officer: CCO & EVP, Bus. Development | 2025-01-31 | M-Exempt | 0 | 2025-02-03 |
| Schafer Joshua | officer: CCO & EVP, Bus. Development | 2025-01-30 | A-Award | 8.02 | 2025-02-03 |
| Schafer Joshua | officer: CCO & EVP, Bus. Development | 2025-01-31 | M-Exempt | 0 | 2025-02-03 |
| Schafer Joshua | officer: CCO & EVP, Bus. Development | 2025-01-30 | A-Award | 0 | 2025-02-03 |
| Clifton R. LaDuane | officer: CFO & Treasurer | 2025-01-31 | M-Exempt | 0 | 2025-02-03 |
| Clifton R. LaDuane | officer: CFO & Treasurer | 2025-01-30 | A-Award | 8.02 | 2025-02-03 |
| Clifton R. LaDuane | officer: CFO & Treasurer | 2025-01-31 | M-Exempt | 0 | 2025-02-03 |
| Clifton R. LaDuane | officer: CFO & Treasurer | 2025-01-30 | A-Award | 0 | 2025-02-03 |
| McFarlane Neil F. | director, officer: President and CEO | 2025-01-31 | M-Exempt | 0 | 2025-02-03 |